Applying Current Evidence on Tailored Therapeutic Strategies to Improve Outcomes for Patients With Myeloproliferative Neoplasms

Download All
In this online program centered around a dynamic CCO webinar, experts discuss recent advances in the management of essential thrombocythemia, polycythemia vera, and myelofibrosis. Watch the on-demand webcast, download the webinar slides, and read expert commentaries on current and emerging therapeutic strategies for patients with MPNs.
Prithviraj Bose, MD
Program Director
Stephen Oh, MD, PhD
Brady L. Stein, MD, MHS

ClinicalThought

In this commentary, experts address HCP questions on MPNs from a live webinar including treatment selection, novel therapeutics, and molecular testing.

Prithviraj Bose, MD
Program Director
Stephen Oh, MD, PhD Brady L. Stein, MD, MHS
Released: May 3, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Geron Corporation
Incyte Corporation
Sumitomo Dainippon Pharma Oncology, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings